Retour
Également cotée sous
SAFLF
OTC
Fourchette du Jour
4,00 €
4,00 €
Fourchette 52 Semaines
2,23 €
4,00 €
Volume
300
Moyenne 50J / 200J
4,00 €
/
3,42 €
Clôture Précédente
4,00 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 25,5 | 0,4 |
| P/B | 3,1 | 2,9 |
| ROE % | 11,7 | 3,7 |
| Net Margin % | 5,0 | 3,9 |
| Rev Growth 5Y % | -0,7 | 10,0 |
| D/E | 0,3 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,00 €
0,00 € – 0,00 €
|
880 M | 0 |
| FY2026 |
0,00 €
0,00 € – 0,00 €
|
840 M | 0 |
Points Clés
Revenue declined -0,65% annually over 5 years
Earnings grew 111,41% over the past year
ROE of 11,71% — decent returns on equity
Debt/Equity of 0,25 — conservative balance sheet
Generating 78,07M in free cash flow
PEG of 0,02 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
-0,65%
Revenue (1Y)-4,90%
Earnings (1Y)111,41%
FCF Growth (3Y)50,43%
Qualité
Return on Equity
11,71%
ROIC9,43%
Net Margin4,99%
Op. Margin6,53%
Sécurité
Debt / Equity
0,25
Current Ratio1,71
Interest Coverage7,76
Valorisation
P/E Ratio
25,54
P/B Ratio3,07
EV/EBITDA20,27
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4,90% | Revenue Growth (3Y) | -3,99% |
| Earnings Growth (1Y) | 111,41% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -0,65% | Earnings Growth (5Y) | 22,00% |
| Profitability | |||
| Revenue (TTM) | 944,57M | Net Income (TTM) | 47,14M |
| ROE | 11,71% | ROA | 6,21% |
| Gross Margin | 60,94% | Operating Margin | 6,53% |
| Net Margin | 4,99% | Free Cash Flow (TTM) | 78,07M |
| ROIC | 9,43% | FCF Growth (3Y) | 50,43% |
| Safety | |||
| Debt / Equity | 0,25 | Current Ratio | 1,71 |
| Interest Coverage | 7,76 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 25,54 | P/B Ratio | 3,07 |
| P/S Ratio | 1,27 | PEG Ratio | 0,02 |
| EV/EBITDA | 20,27 | Dividend Yield | 0,00% |
| Market Cap | 1,20B | Enterprise Value | 1,25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 944,57M | 993,22M | 1,02B | 1,08B | 969,58M |
| Net Income | 47,14M | 22,30M | -24,65M | 54,16M | 21,28M |
| EPS (Diluted) | 0,22 | 0,05 | -0,06 | 0,13 | 0,07 |
| Gross Profit | 575,63M | 592,78M | 601,74M | 597,45M | 445,64M |
| Operating Income | 61,65M | 39,39M | 7,66M | 48,46M | 26,08M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 758,63M | 842,34M | 855,46M | 960,27M | 937,77M |
| Total Liabilities | 355,75M | 414,88M | 459,68M | 521,35M | 571,68M |
| Shareholders' Equity | 392,29M | 413,07M | 379,20M | 409,92M | 326,74M |
| Total Debt | 98,23M | 130,10M | 157,60M | 191,11M | 192,96M |
| Cash & Equivalents | 52,12M | 47,42M | 74,90M | 77,71M | 99,00M |
| Current Assets | 448,13M | 510,56M | 547,67M | 596,30M | 561,89M |
| Current Liabilities | 262,33M | 277,45M | 289,08M | 312,55M | 310,63M |